Danone (OTC: DANOY) Exceeds Q2 Earnings and Revenue Estimates, Boosted by Specialized Nutrition and Strong Sales

• Strong Financial Performance: Danone surpassed analyst expectations for both EPS and revenue in Q2 2026, with recurring EPS increasing by 0.9% and revenue reaching $15.87 billion.
• Sales Growth Drivers: The company achieved a 4.2% like-for-like sales increase, driven by a recovery in specialized nutrition and robust demand for brands like Oikos and Activia, particularly in Japan.
• Positive Outlook: Danone reaffirmed its 2026 guidance, projecting like-for-like sales growth between 3% and 5%, supported by a healthy debt-to-equity ratio of 0.85.

Danone (OTC: DANOY) is a global food and beverage company that focuses on a health and wellness-focused portfolio. The company is known for popular brands such as Activia and Oikos. It operates in a competitive food and beverage market, producing dairy products, plant-based foods, and specialized nutrition products for various age groups and medical needs.

On July 29, 2026, Danone reported an earnings per share (EPS) of $0.44, which successfully beat analyst estimates of $0.43. This positive result is part of a broader trend for the company, which saw its recurring EPS for the first half of 2026 increase by 0.9% to €1.92, driven by its operational performance.

The company also announced revenue of $15.87 billion, exceeding the consensus estimate of $15.72 billion. This strong revenue figure is supported by a 4.2% like-for-like sales increase in the second quarter, as highlighted by Reuters. This growth was a mix of a 1.9% increase in volume and a 2.3% increase from pricing.

The positive sales performance was largely due to a recovery in its specialized nutrition unit, which had previously been affected by product recalls and supply disruptions. As noted by The Wall Street Journal, strong demand from Japan for its Oikos and Activia brands also significantly contributed to the growth.

Looking ahead, Danone confirms its 2026 guidance, expecting like-for-like sales growth between 3% and 5%. The company's financial health includes a debt-to-equity ratio of 0.85. This ratio is a measure of a company's financial leverage, calculated by dividing its total liabilities by its shareholder equity.